We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05005442
Brief Title: A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)

First Submitted : August 12, 2021
First Submitted that Met QC Criteria : August 12, 2021
First Posted : August 13, 2021

Last Update Submitted that Met QC Criteria : September 17, 2022
Last Update Posted : September 21, 2022